We are live on
!
Find out more
COCM
Charter Oak Capital Management Portfolio holdings
AUM
$1.29B
1-Year Est. Return
13.93%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+13.93%
3 Year Est. Return
+39.21%
5 Year Est. Return
+34.61%
10 Year Est. Return
–
AUM
$1.31B
AUM Growth
+$36.6M
(+2.9%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
1.17%
Top 10 Holdings %
Top 10 Hldgs %
76.16%
Holding
212
New
10
Increased
81
Reduced
102
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$28.5M |
| 2 |
Vanguard Total International Stock ETF
VXUS
|
+$7.36M |
| 3 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$5.42M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$4.18M |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$13.8M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$9.77M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.81M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.74M |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.61% |
| 2 | Financials | 1.21% |
| 3 | Healthcare | 1.12% |
| 4 | Industrials | 0.52% |
| 5 | Consumer Discretionary | 0.51% |
Similar funds
MA
ACM
CTA
MB
MCM
GPCM
SPC
HCS
Charter Oak Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Charter Oak Capital Management held 212 positions worth $1.31B, up 2.9% from $1.27B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Charter Oak Capital Management's Q4 2025 filing shows 10 new, 81 increased, 102 reduced and 4 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 958 shares worth $739K. The largest sale was Vanguard Short-Term Bond ETF, an estimated $13.8M.
By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 3.5% a quarter earlier, followed by Financials and Healthcare.
- Charter Oak Capital Management's largest Q4 2025 buy was Regeneron Pharmaceuticals: 958 shares worth $739K.
- Charter Oak Capital Management added most to Vanguard Ultra-Short Bond ETF in Q4 2025, an estimated $28.5M increase.
- Charter Oak Capital Management's biggest Q4 2025 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $13.8M.
- Charter Oak Capital Management fully exited Hartford Financial Services in Q4 2025, selling an estimated $327K.
- Charter Oak Capital Management's ten largest holdings make up 76% of its $1.31B portfolio in Q4 2025.
- Charter Oak Capital Management opened 10 new positions and closed 4 in Q4 2025.
- Charter Oak Capital Management's portfolio value rose 2.9% quarter-over-quarter to $1.31B.
Based on Charter Oak Capital Management's 13F filing for Q4 2025, filed 23 Jan 2026.